Detalhe da pesquisa
1.
EV-301 long-term outcomes: 24-month findings from the phase III trial of enfortumab vedotin versus chemotherapy in patients with previously treated advanced urothelial carcinoma.
Ann Oncol
; 34(11): 1047-1054, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37678672
2.
Efficacy and safety of pembrolizumab in metastatic urothelial carcinoma: results from KEYNOTE-045 and KEYNOTE-052 after up to 5 years of follow-up.
Ann Oncol
; 34(3): 289-299, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36494006
3.
EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees.
Ann Oncol
; 30(11): 1697-1727, 2019 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31740927
4.
Borealis-1: a randomized, first-line, placebo-controlled, phase II study evaluating apatorsen and chemotherapy for patients with advanced urothelial cancer.
Ann Oncol
; 28(10): 2481-2488, 2017 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28961845
5.
Sunitinib in pancreatic neuroendocrine tumors: updated progression-free survival and final overall survival from a phase III randomized study.
Ann Oncol
; 28(2): 339-343, 2017 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27836885
6.
Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: a multi-institution correlative biomarker study.
Ann Oncol
; 28(7): 1508-1516, 2017 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28472366
7.
Sunitinib-induced hypertension in CYP3A4 rs4646437 A-allele carriers with metastatic renal cell carcinoma.
Pharmacogenomics J
; 17(1): 42-46, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26810136
8.
DNA sequence diversity and the efficiency of natural selection in animal mitochondrial DNA.
Heredity (Edinb)
; 118(1): 88-95, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27827387
9.
Clinicopathological differences between familial colorectal cancer type X and sporadic cancer in an isolated area of spain.
Colorectal Dis
; 18(11): O388-O396, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27671100
10.
Pancreatic NETs: where do we stand now?
Cancer Metastasis Rev
; 33(1): 361-6, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24452757
11.
Final results from the large sunitinib global expanded-access trial in metastatic renal cell carcinoma.
Br J Cancer
; 113(1): 12-9, 2015 Jun 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-26086878
12.
Pazopanib in pretreated advanced neuroendocrine tumors: a phase II, open-label trial of the Spanish Task Force Group for Neuroendocrine Tumors (GETNE).
Ann Oncol
; 26(9): 1987-1993, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26063633
13.
Prognostic factors for relapse in stage I seminoma: a new nomogram derived from three consecutive, risk-adapted studies from the Spanish Germ Cell Cancer Group (SGCCG).
Ann Oncol
; 25(11): 2173-2178, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25210015
14.
Prospective study assessing hypoxia-related proteins as markers for the outcome of treatment with sunitinib in advanced clear-cell renal cell carcinoma.
Ann Oncol
; 24(9): 2409-14, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23788753
15.
Lurbinectedin, a selective inhibitor of oncogenic transcription, in patients with pretreated germline BRCA1/2 metastatic breast cancer: results from a phase II basket study.
ESMO Open
; 7(5): 100571, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36037567
16.
Results from the INMUNOSUN-SOGUG trial: a prospective phase II study of sunitinib as a second-line therapy in patients with metastatic renal cell carcinoma after immune checkpoint-based combination therapy.
ESMO Open
; 7(2): 100463, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35405437
17.
Phase II study of sunitinib as first-line treatment of urothelial cancer patients ineligible to receive cisplatin-based chemotherapy: baseline interleukin-8 and tumor contrast enhancement as potential predictive factors of activity.
Ann Oncol
; 22(12): 2646-2653, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21427062
18.
Pneumatosis intestinalis in a radioactive iodine-refractory metastasic thyroid papillary carcinoma with BRAFV600E mutation treated with dabrafenib-trametinib: a case report.
J Med Case Rep
; 15(1): 109, 2021 Mar 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33653337
19.
Atezolizumab in locally advanced or metastatic urothelial cancer: a pooled analysis from the Spanish patients of the IMvigor 210 cohort 2 and 211 studies.
Clin Transl Oncol
; 23(4): 882-891, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32897497
20.
SAUL, a single-arm study of atezolizumab for chemotherapy-pretreated locally advanced or metastatic carcinoma of the urinary tract: outcomes by key baseline factors, PD-L1 expression and prior platinum therapy.
ESMO Open
; 6(3): 100152, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33984672